Founded by pharmaceutical executive and chemist Jennifer Sherak, the brand delivers five times the peptides of leading luxury skincare, combining scientific rigor and elegance to address the evolving skin needs of women's skin in midlife.
Sherak, a biotechnology-driven luxury skincare company founded by chemist and former pharmaceutical executive Jennifer Sherak, today announced the official launch of its Skin Renewal Chemistry System—a three-step regimen powered by the proprietary Pentapeptide Matrix™. The system delivers five times the peptides of leading luxury brands, helping to support the look of firm, resilient, and radiant midlife skin.
"Women over 40 are the most discerning beauty consumers. They are scientifically minded, health-focused, and results-driven; yet the skincare industry has overlooked their specific skincare needs," said Jennifer Sherak, Founder and CEO of Sherak. "At Sherak, we've applied precision to skincare, creating biotechnology-based formulations that meet the real needs of midlife skin."
The debut Sherak System includes:
Targeting the ~$5 billion U.S. luxury skincare market led by women over 40, Sherak is positioned at the intersection of science, luxury, and innovation. The brand combines biotechnology-based innovation, validated actives, and elevated design to redefine skincare for a powerful and underrecognized demographic.
Sherak products are now available at www.SherakSkin.com.